blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3141605

EP3141605 - VARIANT ACTIVIN RECEPTOR POLYPEPTIDES AND USES THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  05.12.2019
Database last updated on 29.06.2024
FormerGrant of patent is intended
Status updated on  26.02.2019
FormerExamination is in progress
Status updated on  11.05.2018
FormerRequest for examination was made
Status updated on  17.11.2017
FormerThe application has been published
Status updated on  10.02.2017
Most recent event   Tooltip05.12.2019Application deemed to be withdrawnpublished on 01.01.2020  [2020/01]
Applicant(s)For all designated states
Amgen, Inc
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
[2017/11]
Inventor(s)01 / SUN, Jeonghoon
4340 Camino De La Rosa
Thousand Oaks, CA 91320 / US
02 / TAM, Lei-ting Tony
3427 Indian Ridge Circle
Thousand Oaks, CA 91362 / US
03 / HAN, Hq
3353 Crossland Street
Thousand Oaks, CA 91362 / US
04 / KWAK, Keith Soo-nyung
1588 Blue Canyon Street
Thousand Oaks, CA 91320 / US
05 / ZHOU, Xiaolan
3876 Rodene Street
Newbury Park, CA 91320 / US
 [2017/11]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2017/11]Campbell, Patrick John Henry
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date16194631.406.03.2008
[2017/11]
Priority number, dateUS20070905459P06.03.2007         Original published format: US 905459 P
US20080065474P11.02.2008         Original published format: US 65474 P
[2017/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3141605
Date:15.03.2017
Language:EN
[2017/11]
Search report(s)(Supplementary) European search report - dispatched on:EP26.01.2017
ClassificationIPC:A61K38/00, C07K14/71
[2019/11]
CPC:
C07K14/71 (EP,CN,KR,US); A61K38/17 (KR); A61P11/00 (EP);
A61P13/00 (EP); A61P13/12 (EP); A61P17/02 (EP);
A61P19/00 (EP); A61P19/02 (EP); A61P19/08 (EP);
A61P21/00 (EP); A61P25/00 (EP); A61P3/00 (EP);
A61P3/04 (EP); A61P3/10 (EP); A61P31/18 (EP);
A61P35/00 (EP); A61P39/06 (EP); A61P43/00 (EP);
A61P9/10 (EP); C07K19/00 (KR); C12N15/63 (KR);
C12P21/00 (KR); A61K38/00 (EP,CN,KR,US); C07K2319/00 (US);
C07K2319/30 (KR,US) (-)
Former IPC [2017/11]C12N15/12, C12N15/861, C12N5/10, C07K14/71, A61K38/17
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/51]
Former [2017/11]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesBA13.11.2017
MK13.11.2017
RS13.11.2017
TitleGerman:ACTIVINREZEPTORPOLYPEPTIDVARIANTEN UND VERWENDUNGEN DAVON[2017/11]
English:VARIANT ACTIVIN RECEPTOR POLYPEPTIDES AND USES THEREOF[2017/11]
French:VARIANTS DE POLYPEPTIDES RÉCEPTEURS D'ACTIVINE ET LEURS UTILISATIONS[2017/11]
Examination procedure19.10.2016Date on which the examining division has become responsible
13.11.2017Amendment by applicant (claims and/or description)
13.11.2017Examination requested  [2017/51]
11.05.2018Despatch of a communication from the examining division (Time limit: M06)
05.11.2018Reply to a communication from the examining division
27.02.2019Communication of intention to grant the patent
10.07.2019Application deemed to be withdrawn, date of legal effect  [2020/01]
16.08.2019Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2020/01]
Parent application(s)   TooltipEP08742032.9  / EP2132314
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
13.11.2017Request for further processing filed
13.11.2017Full payment received (date of receipt of payment)
Request granted
23.11.2017Decision despatched
The application is deemed to be withdrawn due to non-payment of the examination fee
13.11.2017Request for further processing filed
13.11.2017Full payment received (date of receipt of payment)
Request granted
23.11.2017Decision despatched
The application is deemed to be withdrawn due to non-payment of designation fees
TR, SK, SI, SE, RO, PT, PL, NO, NL, MT, MC, LV, LU, LT, IT, IS, IE, HU, HR, GR, GB, FR, FI, ES, EE, DK, DE, CZ, CY, CH, BG, BE, AT
13.11.2017Request for further processing filed
13.11.2017Full payment received (date of receipt of payment)
Request granted
23.11.2017Decision despatched
13.11.2017Request for further processing filed
13.11.2017Full payment received (date of receipt of payment)
Request granted
23.11.2017Decision despatched
Fees paidRenewal fee
19.10.2016Renewal fee patent year 03
19.10.2016Renewal fee patent year 04
19.10.2016Renewal fee patent year 05
19.10.2016Renewal fee patent year 06
19.10.2016Renewal fee patent year 07
19.10.2016Renewal fee patent year 08
19.10.2016Renewal fee patent year 09
10.03.2017Renewal fee patent year 10
13.03.2018Renewal fee patent year 11
13.03.2019Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2004039948  (WYETH CORP [US], et al) [A] 1-15 * paragraph [0012] - paragraph [0021]; claims 1-14; sequence 1 *;
 [A]US2004223966  (WOLFMAN NEIL M [US], et al) [A] 1-15 * paragraph [0012] - paragraph [0069] * * paragraph [0089] - paragraph [0099]; examples 3-5,8,9,11,12; sequence 1 *;
 [E]EP2132314  (AMGEN INC [US]) [E] 1-15* the whole document *
by applicantUS3773919
 EP0036676
 EP0058481
 EP0088046
 US4411993
 EP0133988
 EP0143949
 US4543439
 USRE32011E
 US4816567
 US4902614
 WO9014363
 WO9410332
 WO9409817
 US5595898
 US5693493
 WO0029581
 US6300129
 US2007117130
    - EPPSTEIN ET AL.,, PNAS, (1985), vol. 82, page 3688
    - MCPHERRON ET AL., NATURE (LONDON, (1997), vol. 387, pages 83 - 90
    - ZIMMERS ET AL., SCIENCE, (2002), vol. 296, page 1486
    - OH ET AL., GENES DEV, (1997), vol. 11, pages 1812 - 26
    - VALE ET AL., NATURE, (1986), vol. 321, pages 776 - 779
    - LING ET AL., NATURE, (1986), vol. 321, pages 779 - 782
    - HARRISON ET AL., J. BIOL. CHEM., (2004), vol. 279, pages 28036 - 28044
    - LEE ET AL., PNAS USA, (2001), vol. 98, pages 9306 - 11
    - OH ET AL., GENES DEV, (2002), vol. 16, pages 2749 - 54
    - KINGSLEY ET AL., GENES DEV., (1994), vol. 8, pages 133 - 146
    - MCPHERRON ET AL., Growth factors and cytokines in health and disease, JAI PRESS INC., pages 357 - 393
    - MCPHERRON ET AL., PNAS USA, (1997), vol. 94, pages 12457 - 12461
    - LEE ET AL., PNAS, (2001), vol. 98, page 9306
    - MCPHERRON ET AL., NATURE GENET., (1999), vol. 22, no. 93, pages 260 - 264
    - GAMER ET AL., DEV. BIOL., (1999), vol. 208, no. 1, pages 222 - 232
    - RASMUSSEN ET AL., CYTOTECHNOLOGY, (1998), vol. 28, page 31
    - URLAUB ET AL., PROC. NATL. ACAD. SCI. USA, (1980), vol. 77, pages 4216 - 20
    - GLUZMAN ET AL., CELL, (1981), vol. 23, page 175
    - MCMAHAN ET AL., EMBO J., (1991), vol. 10, page 2821
    - GOEDDELL, D.V.,, Methods of Enzymology, ACADEMIC PRESS, (1990), vol. 185
    - TAM ET AL., J AM CHEM SOC, (1983), vol. 105, page 6442
    - MERRIFIELD, SCIENCE, (1986), vol. 232, pages 341 - 347
    - BARANY; MERRIFIELD, The Peptides, ACADEMIC PRESS, pages 1 - 284
    - BARANY ET AL., INT J PEP PROTEIN RES, (1987), vol. 30, pages 705 - 739
    - SONGSIVILAI ET AL., CLIN. EXP. IMMUNOL., (1990), vol. 79, pages 315 - 321
    - KOSTELNY ET AL., J. IMMUNOL., (1992), vol. 148, pages 1547 - 1553
    - MENDEZ ET AL., NATURE GENETICS, (1997), vol. 15, pages 146 - 156
    - SIDMAN ET AL., BIOPOLYMERS, (1983), vol. 22, pages 547 - 556
    - LANGER ET AL., J. BIOMED. MATER. RES., (1981), vol. 15, pages 167 - 277
    - LANGER ET AL., CHEM. TECH., (1982), vol. 12, pages 98 - 105
    - GONZALEZ-CADAVID ET AL., PNAS USA, (1998), vol. 95, pages 14938 - 14943
    - LANG ET AL., FASEB J, (2001), vol. 15, pages 1807 - 1809
    - ZACHWIEJA ET AL., J GRAVIT PHYSIOL., (1999), vol. 6, no. 2, page 11
    - LALANI ET AL., J.ENDOCRIN, (2000), vol. 167, no. 3, pages 417 - 28
    - YARASHESKI ET AL., J NUTR AGING, (2002), vol. 6, no. 5, pages 343 - 8
    - SHARMA ET AL., J CELL PHYSIOL., (1999), vol. 180, no. 1, pages 1 - 9
    - YEN ET AL., FASEB J., (1994), vol. 8, page 479
    - HAMRICK ET AL., CALCIF TISSUE INT, (2002), vol. 71, no. 1, pages 63 - 8
    - CIPRANO ET AL., ENDOCRINOL, (2000), vol. 141, no. 7, pages 2319 - 27
    - SHOU ET AL., ENDOCRINOL, (1997), vol. 138, no. 11, pages 5000 - 5
    - COERVER ET AL., MOL ENDOCRINOL, (1996), vol. 10, no. 5, pages 534 - 43
    - ITO ET AL., BRITISH J , CANCER, (2000), vol. 82, no. 8, pages 1415 - 20
    - LAMBERT-MESSERLIAN ET AL., GYNECOLOGIC ONCOLOGY, (1999), vol. 74, pages 93 - 7
    - "Methods in Cell Biology", ASAI,, Antibodies in Cell Biology, ACADEMIC PRESS, INC., (1993), vol. 37
    - AKERSTROM, JLMMUNOL, (1985), vol. 135, page 2589
    - CHAUBERT, MOD PATHOL, (1997), vol. 10, page 585
    - BIANCHI ET AL., BIOTECH AND BIOENGINEERING, (2003), vol. 84, no. 4, pages 439 - 444
    - DENNLER ET AL., EMBO, (1998), vol. 17, pages 3091 - 3100
    - MACIAS-SILVA ET AL., CELL, (1996), vol. 87, page 1215
    - MATZUK ET AL., PNAS, (1994), vol. 91, no. 19, pages 8817 - 21
    - CIPRIANO ET AL., ENDOCRINOLOGY, (2000), vol. 121, no. 7, pages 2319 - 27
    - MATZUK ET AL., NATURE, (1992), vol. 360, no. 6402, pages 313 - 9
    - FUJITA ET AL., INT J CANCER, (1996), vol. 68, no. 5, pages 637 - 43
    - KWAK ET AL., CANCER RESEARCH, (2004), vol. 64, no. 22, pages 8193 - 8
    - CARLSON CJ; BOOTH FW; GORDON SE, AM J PHYSIOL REGUL INTEGR COMP PHYSIOL., (1999), vol. 277, pages R601 - RR606
 WO1993US00829
 WO1994US01875
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.